Tyra Biosciences, Inc. Share Price
TYRATyra Biosciences, Inc. Stock Performance
Open $33.00 | Prev. Close $32.99 | Circuit Range N/A |
Day Range $32.40 - $33.25 | Year Range $8.75 - $40.42 | Volume 8,367 |
Average Traded $32.74 |
Tyra Biosciences, Inc. Share Price Chart
About Tyra Biosciences, Inc.
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.
Tyra Biosciences, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-May-26 | $34.66 | $33.43 | -0.95% |
19-May-26 | $34.95 | $33.75 | -5.52% |
18-May-26 | $37.13 | $35.72 | -3.67% |
15-May-26 | $35.76 | $37.08 | +1.39% |
14-May-26 | $35.71 | $36.57 | +1.12% |
13-May-26 | $34.78 | $36.16 | +3.74% |
12-May-26 | $33.63 | $34.86 | +2.57% |